SOPHiA GENETICS (SOPH) Gains from Equity Investments (2024 - 2025)

SOPHiA GENETICS (SOPH) posted Gains from Equity Investments of $90000.0 for Q4 2025, up 114.83% sequentially from -$607000.0 in Q3 2025, and down 13.46% YoY from $104000.0 in Q4 2024.

SOPHiA GENETICS (SOPH) Gains from Equity Investments (2024 - 2025) Analysis & Trends

SOPHiA GENETICS has reported Gains from Equity Investments for 2 years, with the latest figure at $90000.0 in Q4 2025.

  • Quarterly Gains from Equity Investments fell 13.46% year-over-year to $90000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$497000.0 (changed N/A YoY) and the FY2025 annual result came in at -$1.9 million, down 409.46% from the prior year.
  • Gains from Equity Investments rose to $90000.0 in Q4 2025 per SOPH's latest filing, from -$607000.0 in the prior quarter.
  • Over five years, Gains from Equity Investments peaked at $182000.0 in Q3 2024 and troughed at -$607000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 39.72 Bn 32.40 Bn 662.02 Mn
2 BrightSpring Health Services 12.19 Bn 11.64 Bn 492.75 Mn
3 Healthequity 8.79 Bn 8.52 Bn 256.31 Mn
4 10x Genomics 7.31 Bn 6.76 Bn 112.50 Mn
5 Hinge Health 7.10 Bn 6.71 Bn 183.95 Mn
6 MiniMed 5.66 Bn 5.36 Bn 480.00 Mn
7 Waystar Holding 4.76 Bn 4.56 Bn 221.99 Mn
8 Doximity 4.46 Bn 3.77 Bn 132.93 Mn
9 Heartflow 3.66 Bn 3.28 Bn 53.19 Mn
10 SOPHiA GENETICS 553.79 Mn 446.12 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 90,000.00
Dec 31, 2025 90,000.00
Sep 30, 2025 -607,000.00
Sep 30, 2025 -607,000.00
Jun 30, 2025 58,000.00
Jun 30, 2025 58,000.00
Mar 31, 2025 -38,000.00
Mar 31, 2025 -38,000.00
Dec 31, 2024 104,000.00
Dec 31, 2024 104,000.00
Sep 30, 2024 182,000.00
Sep 30, 2024 182,000.00
Jun 30, 2024 84,000.00
Jun 30, 2024 84,000.00